FDA Approves Implant for Glaucoma FDA Approves Implant for Glaucoma

An intracameral implant that releases travoprost into the eye over an extended period to lower intraocular pressure in glaucoma and ocular hypertension will be available commercially in early 2024.Medscape Medical News
Source: Medscape Pharmacist Headlines - Category: Drugs & Pharmacology Tags: Ophthalmology Source Type: news